On 11 March, Aevi Genomic Medicine, Inc. (GNMX) made the way into the market positive movers list with rising 4.04%. GNMX reported a change of 4.39% over the last week and performed 1.91% over the last month while its year to date (YTD) performance revealed an activity trend of -68.71%. GNMX quarterly performance specifies a shift of -79.53%. The stock price closed last trading at $0.22. Aevi Genomic Medicine, Inc. (GNMX) negotiated 1.26 million shares and maintained an average volume of 2.32 million shares. Volume analysis is used by technical analysts as one of many factors that inform their trading decisions. By analyzing trends in volume in conjunction with price movements, investors can determine the significance of changes in a security’s price. Volume typically increases as price increases and vice versa; when the opposite occurs, it’s called divergence. With approx. 63.51 million shares in outstanding, the company has a market cap of $13.91 as per the current valuation. Calculating the market cap is easy. Market capitalization is simply the value that can get when multiply all the outstanding shares of a stock by the price of a single share.
Technical Look at Aevi Genomic Medicine, Inc. (GNMX): (Is this is BUY or SELL time?)
Moving average technique is used to smooth the data and identify the underlying price trend. Simple BUY signals occur when prices close above the moving average; SELL signals occur when prices fall below the moving average. Aevi Genomic Medicine, Inc. (GNMX)’s stock price closed below with -76.86% gap from 200 day simple moving average and its downbeat distance from 50 day simple moving average is -17.06%, while finished with 3.03% Bullish trend from 20 day simple moving average. Moving averages are among the easiest-to-use tools available to market technicians. A simple moving average is calculated by adding the closing prices of a stock over a specified number of time periods, usually days or weeks.
Twenty-day SMA is useful at identifying swing trading trends lasting twenty days. Shorter moving average timeframes are more sensitive to price fluctuations and can pick up on trend changes more quickly than longer-term moving averages. However, these more frequent signals may also result in more “whipsaws”, resulting in erroneous trade signals. GNMX recently closed with rise of 3.03% to its twenty-Day SMA. This short time frame picture represents an upward movement of current price over average price of last twenty days.
GNMX holds Low or High volatility?
Aevi Genomic Medicine, Inc. (GNMX) has ATR reading of 0.02. A stock’s Average True Range (ATR) is the difference between the high and low price on any given day. It reveals information about how volatile a stock is. Large ranges indicate high volatility and small ranges indicate low volatility. The range is measured the same way for options and commodities – high minus low – as they are for stocks.
By seeing it past volatility it showed that volatility for the week is 9.46% while volatility for the month is 9.69%.
Relative Strength Index (RSI)
Aevi Genomic Medicine, Inc. (GNMX)’s Relative Strength Index (RSI) is 53.76. RSI is a technical indicator of price momentum, comparing the size of recent gains to the size of recent losses and establishes oversold and overbought positions. Average True Range (14) for Aevi Genomic Medicine, Inc. (GNMX) is stands at 0.02. ATR is a volatility indicator. Volatility measures the strength of the price action, and is often overlooked for clues on market direction.